Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]

Affiliations

¹ The Zucker Hillside Hospital, Department of Psychiatry Research, 75-59 263rd Street, Glen Oaks, NY 11004, USA; Hofstra North Shore-LIJ School of Medicine, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Electronic address: ccorrell@nshs.edu.
² Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center Drive, 1 University Square Drive, Princeton, NJ 08540, USA.
³ H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Copenhagen, Denmark.
⁴ The Zucker Hillside Hospital, Department of Psychiatry Research, 75-59 263rd Street, Glen Oaks, NY 11004, USA.

Published Erratum

Christoph U Correll et al. Schizophr Res. 2017 Dec.

. 2017 Dec:190:191-194.

doi: 10.1016/j.schres.2017.02.030. Epub 2017 Mar 25.

¹ The Zucker Hillside Hospital, Department of Psychiatry Research, 75-59 263rd Street, Glen Oaks, NY 11004, USA; Hofstra North Shore-LIJ School of Medicine, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Electronic address: ccorrell@nshs.edu.
² Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center Drive, 1 University Square Drive, Princeton, NJ 08540, USA.
³ H. Lundbeck A/S, Ottiliavej 9, 2500, Valby, Copenhagen, Denmark.
⁴ The Zucker Hillside Hospital, Department of Psychiatry Research, 75-59 263rd Street, Glen Oaks, NY 11004, USA.

No abstract available

Erratum for

Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies.
Correll CU, Skuban A, Hobart M, Ouyang J, Weiller E, Weiss C, Kane JM. Correll CU, et al. Schizophr Res. 2016 Jul;174(1-3):82-92. doi: 10.1016/j.schres.2016.04.012. Epub 2016 May 4. Schizophr Res. 2016. PMID: 27157799 Review.